The national patient teleconference/webinar Spotlight on Parkinson’s Disease: What’s New in PD Treatments, is now available. To access the webinar, please click the link below which will take you directly into the program. You will also be able to access the webinar slides, transcript of webinar, and APDA resources. http://www.aoic.net/APDA/APDA19359arc/ The presenters are: Marie Saint […]
A Brigham research team led by Clemens Scherzer, MD, director of the Center for Advanced Parkinson Research and Precision Neurology Program in the Department of Neurology, has been selected by the Aligning Science Across Parkinson’s (ASAP) initiative to receive $9 million over three years. Scherzer will lead a project titled “Parkinson5D: Deconstructing Proximal Disease Mechanisms […]
10.3% of “sporadic” Parkinson’s patients carry one copy out of a myriad of distinct GBA mutations. The type of GBA mutation found in a patient modulates the clinical course, but the biochemical mechanism is unclear. In an article published in Neurology in the August, 2020 edition, a team of investigators led by Clemens Scherzer from […]
Clemens Scherzer Physician-scientist Clemens Scherzer, MD, wants to change the future of the treatment of Parkinson’s disease. In the lab, his team focuses on predicting and preventing disease progression, and on developing precision drugs and biomarkers tailored to individual patients. Scherzer is center director for the American Parkinson’s Disease Association Center for Advanced Parkinson’s Disease […]
Mel Feany, MD, PhD, from the Department of Pathology, received the 2019 Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institute of Health. The Landis Award, named in honor of former NINDS Director Story Landis, PhD, recognizes individuals who have shown dedication to mentorship and […]
On Sunday, June 23rd 2019, the American Parkinson’s Disease Association‘s Massachusetts Chapter held the 33rd Annual Massachusetts Optimism Walk for Parkinson’s disease at Bowditch Field in Framingham, MA. The weather was perfect for this well-attended event, which gave patients, caregivers, friends, family members, scientists, and clinicians the opportunity to mingle and raise donations for Parkinson’s […]
Tai Chi for Parkinson’s disease: 12-week summer course July 2, 2019 – September 24, 2019 Tuesdays, 7:00PM – 8:00PM Fishbowl Conference Room, Side A, 2nd Floor, 850 Boylston Street Chestnut Hill, MA 02467 Stanwood Change is a certified instructor of the Tree of Life Tai Chi program and the Program Manager for the Eight […]
Precision therapies are on the horizon, but are they precise enough? _____ The first generation of precision medicine therapies for Parkinson’s disease (PD) should enter phase 3 clinical trial in 2019. If even one of them succeeds in modifying disease progression it will open the doors for more targeted therapies and officially mark the beginning […]
Press Release: CZI Awards Over $51 Million to Fight Neurodegenerative Disorders, Including Alzheimer’s and Parkinson’s The Neurodegeneration Challenge Network Brings Together Interdisciplinary Experts to Accelerate Our Understanding of Neurodegenerative Diseases Redwood City — December 5, 2018 — Today, the Chan Zuckerberg Initiative (CZI) announced $51.95 million in funding and its selection of 17 early career […]
The iPSC NeuroHub aims to make iPSCs, tools, and protocols accessible to labs studying neurological diseases within the ARCND iPSC NeuroHub.
Center for Advanced Parkinson Research
capr@bwh.harvard.edu
857.307.5422
Connect • Giving • Lean in
Clinic appointments • Photo Credits
We are grateful for the support of the APDA. 